[Taxol in advanced cervical cancer].
Hirabayashi
Kei
K
Division of Obstetrics and Gynecology, Tokuyama Central Hospital.
Ito
Jun
J
Kobayashi
Masayuki
M
Numa
Fumitaka
F
Ito
Takehisa
T
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D014407:Tumor Cells, Cultured; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D002945:Cisplatin; D005472:Fluorouracil